
Entecavir add-on Peg-interferon therapy plays a positive role in reversing hepatic fibrosis in treatment-naïve chronic hepatitis B patients: a prospective and randomized controlled trial
Author(s) -
Jincheng Yang,
Chen Li-ping,
Yajie Wang,
Bei Lyu,
Hong Zhao,
Zhiyin Shang,
Jun Li,
Zhenyu Fan,
Shengdi Wu,
Xiao Ming,
Xian Li,
Shaoping Huang,
Jun Cheng
Publication year - 2020
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000000857
Subject(s) - medicine , hbsag , entecavir , seroconversion , hbeag , gastroenterology , combination therapy , transient elastography , pegylated interferon , hepatitis b virus , hepatitis b , alanine transaminase , immunology , liver biopsy , antibody , virus , chronic hepatitis , lamivudine , biopsy , ribavirin